3 June 2026 - The Albanese Government is continuing to deliver cheaper medicines with Australians with types of leukaemia and severe migraines to pay less for expanded PBS medicines from 1 June 2026.
Acalabrutinib (Calquence) will be expanded to offer new treatments for people with untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma.